REWALK ROBOTICS LTD (RWLK) Stock News
NASDAQ:RWLK - Nasdaq - IL0011331076 - Common Stock - Currency: USD
RWLK Latest News, Press Relases and Analysis
VA STAND Act introduced in the United States Senate
Bicameral legislation seeks to codify annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with...
Mentions: LFWD
Lifeward Announces Reverse Share Split
Mentions: LFWD
Lifeward Announces Reverse Share Split
Reverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and profitability target for 2026 on...
Mentions: LFWD
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to...
Mentions: LFWD
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
Mentions: LFWD
The 3 Best Penny Stocks to Buy in November
While even the best penny stocks carry significant risk, these compelling ideas just might be worth a closer examination.
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be
Mentions: LFWD
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be
The decision was communicated through CMS’ bi-annual Healthcare Common Procedure Coding System (“HCPCS”) coding memorandum released yesterday; payment...
Mentions: LFWD
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
Mentions: LFWD
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
Highest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in...
Mentions: LFWD
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or...
Mentions: LFWD
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
Mentions: LFWD
Get Rich Quick With These 7 Robotics Stocks to Buy Now
Discover seven robotics stocks set for growth, with innovations driving the future of automation and industry.
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical...
Mentions: LFWD
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
Mentions: LFWD
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant.
ReWalk Robotics Expands Direct Sales Coverage to Canada
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the...
ReWalk Robotics Expands Direct Sales Coverage to Canada
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”)...
First ReWalk Personal Exoskeleton Claim Paid by Medicare
ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury...
First ReWalk Personal Exoskeleton Claim Paid by Medicare
ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
ReWalk supports “gap-filling” pricing method proposed by CMS with use of up-to-date pricing information....
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
ReWalk supports “gap-filling” pricing method proposed by CMS with use of up-to-date pricing information.
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
Although growth penny stocks present extraordinary risks, if you exercise meticulous care, these ideas might be worth a shot.
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype...
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype
7 Cheap Stocks to Buy Now if You Have $100 to Spend: November Edition
Uncover these top three cheap stocks to buy for substantial portfolio expansion ahead of a likely bull run in 2024.
ReWalk Robotics Reports Third Quarter 2023 Financial Results
ReWalk Robotics Reports Third Quarter 2023 Financial Results
Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts...
New Bill Facilitates Veteran Access to Powered Exoskeletons
Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of...
New Bill Facilitates Veteran Access to Powered Exoskeletons
Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons
ReWalk Robotics to Discuss Medicare’s Preliminary Payment Determination for ReWalk Personal Exoskeleton
Conference Call on Wednesday, November 8, 2023, at 8:30 a.m. EST
ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023
In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton
Medicare Coverage Solidified for ReWalk Personal Exoskeleton
2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons. Final rule expedites access for Medicare beneficiaries...